Fingolimod Versus Dimethyl-fumarate in Multiple Sclerosis

Stopped termination of the study due to the slowness of the recruitment activity, according to the contract signed with the Sponsor

Conditions

• Relapsing Remitting Multiple Sclerosis

Interventions

• DRUG: Fingolimod
• DRUG: Dimethyl Fumarate

Sponsor

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Collaborators

• [object Object]
• [object Object]